The Synthetic Biology Innovation Network

Could Fermentation Power The Future Of Plant-Based Foods? Motif FoodWorks Thinks Yes.

Motif FoodWorks is leveraging the power of microbe engineering and fermentation to revolutionize the future of plant-based foods.

Demetrix Is Scaling The Cannabinoid Industry

Berkeley-based Demetrix announced today that it has commenced 15,000-liter demo-scale fermentation production of CBG, the first rare cannabinoid it will take to market.

The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicines

In a Nature paper published today, Smolke and her lab report a breakthrough in making plant-based medicines that lays the foundation for a flexible, on-demand drug supply chain

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

A timely contest calls for biotech innovators to join the effort to develop frequent, fast, cheap, and easy COVID testing

Featured

COVID-19 Resources

SynBioBeta is proud to partner with Leaps by Bayer to make a visual timeline for COVID-19 treatment and prevention. The scientific community is working around the clock, not only to protect us from COVID-19, but to...

Editors' picks

Could Fermentation Power The Future Of Plant-Based Foods? Motif FoodWorks Thinks Yes.

What is the future of food? Looking at what’s on shelves and in freezers during a quick trip to the local grocery store, it’s easy to see that we are quickly moving towards a future of plant-based foods. While they...

Demetrix Is Scaling The Cannabinoid Industry

The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicines

When Covid hit and hospitals started reporting shortages of hydroxychloroquine and other medicines vital to patients with conditions like malaria, lupus, asthma, and COPD, it became clear that our drug supply chain was...

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

Emily Leproust, CEO, and Aaron Sato, CSO of Twist Bioscience. TWIST BIOSCIENCE

How A Newly Public Synthetic Biology Company Pivoted To The Pandemic: Up Close And Personal With Twist Bioscience

A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain

By zeroing in on a notorious class of enzymes associated with cancer, Reverie Labs puts the power of cloud computing to its full potential Can two smart, motivated college grads start a pharmaceutical company in an...

The Rush For Hand Sanitizers Is A Boom For Hand Moisturizers. This Startup Has A Solution For Both.

Can Technology Make More Natural Pesticides? Zymergen-FMC Partnership Offers A Peek Into The Future Of Crop Protection

A new collaboration between the two R&D pioneers aims to accelerate the discovery of breakthrough crop protection technologies If you ask two farmers what it really takes to bring healthy and affordable food to...

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital

Automated Biology Is Now an Affordable Reality

View all posts

Press releases

Amyris’ Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles’ Day Sales

EMERYVILLE, Calif., Sept. 21, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of...

$1.5 billion invested in alternative proteins in 2020, including a record $435 million in the next pillar—fermentation

Inaugural report reveals fermentation as the next pillar of alternative proteins, enabling a new wave of innovative products and accelerating the industry WASHINGTON – A first-of-its kind report released today by The...

Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene Editing

Second collaboration between Moderna and Vertex based on Moderna’s proprietary mRNA and LNP technology Collaboration will leverage Vertex’s investments and capabilities in genetic technologies for CF Moderna to receive...

Debut Biotechnology Awarded $1M from Air Force Research Lab to Leverage Cell-Free Continuous Biomanufacturing in Aerospace Applications

Debut Bio’s biosynthesis platform provides a scalable biomanufacturing approach while eliminating the need for traditional precious metal catalysts and toxic reagents SAN DIEGO (PRWEB) SEPTEMBER 15, 2020 Debut...

Featured

COVID-19 Resources

Editors' picks

Could Fermentation Power The Future Of Plant-Based Foods? Motif FoodWorks Thinks Yes.

Demetrix Is Scaling The Cannabinoid Industry

The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicines

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

How A Newly Public Synthetic Biology Company Pivoted To The Pandemic: Up Close And Personal With Twist Bioscience

A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain

The Rush For Hand Sanitizers Is A Boom For Hand Moisturizers. This Startup Has A Solution For Both.

Can Technology Make More Natural Pesticides? Zymergen-FMC Partnership Offers A Peek Into The Future Of Crop Protection

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital

Automated Biology Is Now an Affordable Reality

Press releases

Amyris’ Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles’ Day Sales

$1.5 billion invested in alternative proteins in 2020, including a record $435 million in the next pillar—fermentation

Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene Editing

Debut Biotechnology Awarded $1M from Air Force Research Lab to Leverage Cell-Free Continuous Biomanufacturing in Aerospace Applications

Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada

Sherlock Biosciences Launches The 221b Foundation to Address the COVID-19 Pandemic and Equity in STEM

Ansa Biotechnologies Raises $9.2 Million in Combined Seed and Pre-Seed Financing

Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer

Evonetix and Analog Devices Collaborate on Third-Generation DNA Synthesis Platform

DNA-based Data Storage and Computation Provider CATALOG, Founded by MIT Scientists, Raises $10 Million

Zymergen Takes Aim at $3 Trillion Chemical & Materials Industry With $300 Million in New Funding

Biopharma Leaders Unite to Stand with Science

News by topic

Agriculture

Health and medicine

Funding & investments

Biomanufacturing, chemicals & materials

Emerging technologies

Food and nutrition

Consumer goods

Energy & environment

Policy & public